Recruiting Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients NCT07176312 Conditions Digestive System Diseases, Digestive System Neoplasms, First Line Therapy, +14 more Locations Charité CVK — Berlin, Germany Vivantes Klinikum im Friedrichshain — Berlin, Germany Klinikum Bielefeld — Bielefeld, Germany Städtisches Klinikum Dresden — Dresden, Germany View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
